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Abstract: The use of visible light emitting diodes (LEDs) as an alternative 
to Q-switched lasers conventionally used as photoacoustic excitation 
sources has been explored. In common with laser diodes, LEDs offer the 
advantages of compact size, low cost and high efficiency. However, laser 
diodes suitable for pulsed photoacoustic generation are typically available 
only at wavelengths greater than 750nm. By contrast, LEDs are readily 
available at visible wavelengths below 650nm where haemoglobin 
absorption is significantly higher, offering the prospect of increased SNR 
for superficial vascular imaging applications. To demonstrate feasibility, a 
range of low cost commercially available LEDs operating in the 420-620nm 
spectral range were used to generate photoacoustic signals in 
physiologically realistic vascular phantoms. Overdriving with 200ns pulses 
and operating at a low duty cycle enabled pulse energies up to 10µJ to be 
obtained with a 620nm LED. By operating at a high pulse repetition 
frequency (PRF) in order to rapidly signal average over many acquisitions, 
this pulse energy was sufficient to generate detectable signals in a blood 
filled tube immersed in an Intralipid suspension (µs’ = 1mm
1
) at a depth of 
15mm using widefield illumination. In addition, a compact four-wavelength 
LED (460nm, 530nm, 590nm, 620nm) in conjunction with a coded 
excitation scheme was used to illustrate rapid multiwavelength signal 
acquisition for spectroscopic applications. This study demonstrates that 
LEDs could find application as inexpensive and compact multiwavelength 
photoacoustic excitation sources for imaging superficial vascular anatomy. 
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1. Introduction 
Photoacoustic imaging is a hybrid imaging technique, which combines the high spectroscopic 
based contrast of optical imaging with the high spatial resolution (<100μm) of ultrasound 
imaging [1]. Q-switched Nd:YAG pumped OPO, Ti:Sapphire or dye laser systems are most 
commonly used as excitation sources in widefield photoacoustic tomography or acoustic 
resolution photoacoustic microscopy. These laser systems can provide the necessary mJ pulse 
energies with nanosecond pulse durations at biologically relevant wavelengths and have 
played an essential role in the development of photoacoustic imaging in the laboratory. 
However, their high cost, large physical size, cooling and maintenance requirements can limit 
their practical biomedical application. 
Laser diodes can address some of these drawbacks as they are relatively inexpensive, 
highly compact and power efficient. High peak power pulsed laser diodes (HPLD) of the type 
designed for LIDAR and other ranging applications have previously been used for 
photoacoustic imaging [2–4]. These studies suggest that, despite the much lower intrinsic 
pulse energy of a single element HPLD (~µJ) compared to Q-switched Nd:YAG based laser 
systems (mJ), it is possible to achieve adequate SNR for superficial imaging applications. 
This typically requires combining multiple emitters (e.g. stacking laser diodes can provide 
pulse energies in the mJ range [4]) and employing optimised signal processing strategies that 
exploit the ability to arbitrarily pulse modulate HPLDs at high repetition frequencies [2–4]. 
However, HPLDs are typically commercially available only at wavelengths greater than 
750nm where haemoglobin absorption, the principal source of endogenous photoacoustic 
contrast, is low. LEDs could offer a useful alternative in this respect. They are available at 
shorter wavelengths below 650nm (see Fig. 1) where haemoglobin absorption can be as much 
as an order of magnitude higher offering the prospect of significantly increased SNR for 
superficial vascular imaging. However, unlike HPLDs designed for LIDAR which can readily 
provide 100s of Watts over nanosecond timescales corresponding to tens of µJ pulse energies 
[2], most commercially available LEDs are specified for continuous wave operation at only a 
few Watts. In this study, we explore the prospect of overcoming this limitation by overdriving 
visible LEDs by a factor of 10 with short pulses and operating at a low duty cycle (<1%) [5]. 
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We show that this strategy enables pulse energies of the order of 10µJ to be achieved over 
nanosecond timescales, more than a factor of 20 higher than previously reported [6] for an 
LED based photoacoustic source. These pulse energies are comparable to those of 905nm 
HPLDs used previously to obtain in vivo photoacoustic images [3], but with the advantage 
that haemoglobin absorption is significantly higher at the visible wavelengths of the LEDs 
used. 
 
Fig. 1. Optical spectra for a range of commercially available LEDs (Mightex Systems). 
Section 2 demonstrates that photoacoustic signals can be generated and detected in a 
realistic tissue mimicking phantom when overdriving an LED and using widefield 
illumination. In Section 3, the LED is used in conjunction with a cylindrical scanner to 
illustrate its application to photoacoustic tomography. The spectroscopic capability of LEDs 
is demonstrated in Section 4 by using a four wavelength device to acquire single point 
measurements in a realistic tissue mimicking phantom. Section 5 illustrates how the use of 
coded excitation can be used to improve SNR and acquire photoacoustic signals at multiple 
wavelengths simultaneously. 
2. Single point measurements in a tissue mimicking phantom 
Figure 2(a) shows the experimental setup used to investigate the use of an LED to generate 
and detect a photoacoustic signal in a realistic tissue mimicking phantom. The phantom 
comprised a 580µm diameter PMMA tube filled with human blood at a physiologically 
realistic concentration (35% haematocrit) and immersed to a depth of 5mm in a 1% 
suspension of intralipid, providing a reduced scattering coefficient of μs’ = 1mm
1
, which is 
comparable to that of soft tissues such as those in the breast [7] and skin [8]. The phantom 
was illuminated by a high power LED (SST-90 from Luminus), driven by a commercial 
driver (PCO-7120, Directed Energy, Inc.), which provided a pulse duration of 200ns, a peak 
current of 50A and a PRF of 500Hz. The duty cycle was 0.01%, which is well below the 1% 
duty cycle previously reported as safe (no noticeable damage to the device) when overdriving 
LEDs by 20 times their nominal current [9]. The optical pulse energy P and wavelength λ of 
the device were 9μJ and 623nm respectively, and the beam diameter incident on the intralipid 
solution was approximately 1cm. A cylindrically focused PZT detector (3.5MHz, V383 
Panametric) with a focal length of 33mm was used to detect the photoacoustic signals and the 
blood-filled tube was placed at the focus of the ultrasound detector. The photoacoustic signal 
was amplified using a low noise voltage amplifier (60dB, Analog Modules Inc), averaged 
1000 times and downloaded to a personal computer (PC). Figure 2(b) shows the detected 
photoacoustic signal for which the SNR was measured to be 7. 
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 Fig. 2. (a) Experimental setup, comprising a 580µm diameter blood filled tube immersed in 
intralipid (µs’ = 1mm
1), (b) Photoacoustic signal (S) generated in a phantom. At t = 27μs a 
reflection (A) of the photoacoustic signal can be seen which is due the acoustic impedance 
mismatch between the intralipid and the wall of the tank. T denotes the trigger and B is a signal 
generated in the tank wall. P = 9µJ, N = 1000 
3. Photoacoustic imaging of a tissue mimicking phantom 
Figure 3(a) shows a schematic of the experimental setup used to demonstrate the use of an 
LED for widefield photoacoustic tomography. The setup used the cylindrically focused PZT 
detector and LED described in Section 2. The LED driving parameters also remained the 
same. The phantom comprised three 1.4mm diameter PMMA tubes filled with human blood 
(35% haematocrit) which were immersed in 1% intralipid (μs’ = 1mm
1
). All three tubes were 
located in a mount which was rotated by 360 degrees in steps of 0.9 degrees using a stepper 
motor. The tubes were placed perpendicular to the focal plane of the ultrasound detector and 
within its focal zone. The LED was located on the opposite side of the ultrasound detector in 
order to operate in forward mode. The light emitted by the LED was transmitted through the 
transparent tank wall (Perspex) and formed an incident beam diameter of approximately 1cm 
on the intralipid suspension. The detected photoacoustic signals were averaged 5000 times. 
The time resolved photoacoustic signals were corrected for the exponential decay of light as a 
function of depth, and time reversal [10] was used to reconstruct a photoacoustic image. 
 
Fig. 3. (a) Photoacoustic imaging setup (b) Time-resolved photoacoustic signals of three 
1.4mm tubes filled with human blood (35% haematocrit) and immersed in 1% Intralipid (μs’ = 
1mm1), (c) Reconstructed photoacoustic image. P = 9µJ, N = 5000. 
Figure 3(b) shows the detected time resolved photoacoustic signals as a function of scan 
angle. It can be seen that photoacoustic signals corresponding to a penetration depth of up to 
1.5cm are clearly visible. The photoacoustic image reconstructed from these signals is shown 
in Fig. 3(c) and clearly reveals all three tubes in the phantom. The tube diameters were 
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measured from the reconstructed image and found to be within 0.1mm of their nominal 
values. The image contrast ratio was measured to be 11.5. 
4. Multiwavelength measurements 
Multiwavelength photoacoustic imaging has the ability to spectroscopically identify and 
quantify the concentration of specific chromophores [11, 12] such as oxyhemoglobin and 
deoxyhemoglobin. To demonstrate the potential spectroscopic capability of LED based 
devices, a compact (total foot print: 12mm
2
) four wavelength device (LZC-03MA07, from 
LedEngin) was used to obtain photoacoustic spectra in a tissue mimicking phantom. The LED 
comprised 4 groups of 3 LEDs (see Fig. 4(a)), each set emitting at one of the following 
wavelengths: 460, 530, 590 and 620nm with respective pulse energies of 1.8, 0.4, 1.7, 2.7μJ. 
To achieve these pulse energies the LEDs were overdriven by ten times their CW current 
limit. The pulse duration and PRF were 200ns and 500Hz respectively. 
Figure 4(b) shows the experimental setup. A 2.4mm diameter tube was filled with human 
blood (35% haematocrit) and immersed to a depth of 5mm in a 1% suspension of intralipid 
(µs’ = 1mm
1
). The multi-wavelength LED illuminated one side of the tube, and a 
cylindrically focused PZT detector (3.5MHz, V383 Panametric) of focal length 33mm was 
placed on the opposite side to detect the generated photoacoustic signals. The detected signals 
were amplified using a preamp (8dB, Precision Acoustics Ltd) and a low noise voltage 
amplifier (40dB gain, model 322-8-B-50 Analog module Inc) and averaged 10000 times. 
 
Fig. 4. (a) Schematic and photograph of the four wavelength LED, (b) Experimental setup, 
comprising a 2.4mm diameter blood filled tube immersed in a solution of intralipid (µ’s = 
1mm1). 
Figure 5 shows the generated photoacoustic signals for each of the four wavelengths. The 
SNR was measured to be 5.7, 1.59, 4.15, and 3.5 at 460, 530, 590, and 620nm respectively. 
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 Fig. 5. Photoacoustic signals generated in a realistic tissue mimicking phantom at (a) λ = 
460nm, P = 1.8µJ, N = 10,000 (b) λ = 530nm, P = 0.4 µJ, N = 10,000 (c) λ = 590nm, P = 1.7 
µJ, N = 10,000 and (d) λ = 620nm, P = 2.7 µJ, N = 10,000. 
The peak amplitudes of the detected photoacoustic signals were normalised to their 
respective pulse energy and plotted as a function of wavelength as shown in Fig. 6 alongside 
the absorption spectra of oxy- and deoxy-haemoglobin. Although the oxygenation level of the 
blood filled tube was unknown, the relative trend in the measured photoacoustic spectra is 
broadly consistent with the absorption spectra of oxy- and deoxy-haemoglobin. 
 
Fig. 6. Absorption spectra of oxy and deoxy haemoglobin overlaid by the photoacoustic spectra 
obtained from the blood filled tube using the four wavelength device. 
As previously mentioned, the main challenge in using LEDs is to overcome the low SNR 
of the generated photoacoustic signals. Using a multi-wavelength device, as opposed to a 
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single wavelength device, can further limit the pulse energy, as the total emitting area of the 
device will be shared between wavelengths. For example, the single wavelength SST-90 
device used in Sections 2 and 3 had a 9mm
2
 emitting area, whereas the multi-wavelength 
device used in this section had a total emitting area of 12mm
2
 divided into four individual 
emitting elements (one for each wavelength), each corresponding to a 3mm
2
 area. Since the 
pulse energy scales with emitting area, the pulse energy provided at a single wavelength by 
the multi-wavelength device will be 3 times lower than that provided by a larger area single-
wavelength device. However there is the potential to mitigate this by driving all four elements 
simultaneously [13] and using the frequency spectrum of the resulting photoacoustic signal to 
design a Wiener filter. The filter can then be applied to the signals generated using a single 
element in order to supress those frequency components associated with the noise, and retain 
only those that contribute to the signal thereby improving SNR. Implicit in this approach is 
the assumption that the bandwidth of the Wiener filter is sufficiently wide to accommodate 
the full extent of the different frequency spectra of the signals generated at each wavelength. 
This appears intuitively reasonable given that the filter design is derived from the 
photoacoustic signal generated at all four wavelengths simultaneously. 
To illustrate the use of a Wiener filter in this way, all four elements were driven 
simultaneously and the time domain photoacoustic signal and its corresponding frequency 
spectrum are shown in Fig. 7(a) (blue curve). For comparison the photoacoustic signal 
obtained using the 620nm emitting element alone (red curve) is also shown in Fig. 7(a). The 
power spectrum  
2
C f of the detected photoacoustic signal generated by all four 
wavelengths can be expressed as: 
      
2 2 2
C f S f N f   (1) 
where  
2
S f  is the power spectrum of the noise free photoacoustic signal generated by all 4 
wavelengths and  
2
N f  is the noise power spectrum. A Wiener filter  H f  is defined as: 
  
 
   
2
2 2
S f
H f
S f N f


 (2) 
and can then be used to filter a photoacoustic signals generated by a single wavelength. This 
filter approaches zero when    
2 2
N f S f , and one when    
2 2
N f S f . Using 
Eq. (1) and 2,  H f  can be rewritten as a function of the power spectrum of the measured 
photoacoustic signal  
2
C f  and the noise  
2
N f : 
  
   
 
2 2
2
C f N f
H f
C f

  (3) 
To design the filter  H f , an estimate of  
2
N f  is required. This can be obtained by 
identifying a part of the time domain signal not containing any photoacoustic signal (for 
example, the part before the trigger), calculating the Fourier transform, and fitting a curve to 
the peaks of the Fourier spectrum. The resulting estimate of  N f  is plotted in Fig. 7(b). 
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 Fig. 7. Photoacoustic signals obtained when driving all four wavelength simultaneously and for 
a single wavelength at λ = 620nm. a) Time domain signals b) frequency domain signals. 
Filtering the photoacoustic signals generated by a single wavelength (
1
C ) then yields: 
 
1 1
( ) [ ( ( )) ( )]Y t IFFT FFT C t H f    (4) 
where 
1
Y denotes the filtered signal. Such a filter will strongly attenuate the frequency 
components which do not contribute to the signals, and preserve those which do. Figure 8 
shows the photoacoustic signals before and after being filtered using  H f . Before filtering, 
the SNRs of the photoacoustic signals were 5.7, 1.59, 4.15 and 3.5 at 460nm, 530nm, 590nm 
and 620nm, respectively. After filtering, the SNRs were 11.8, 2.2, 6.8 and 6, thus 
corresponding to an average SNR improvement of a factor of 1.7 compared to that obtained in 
Fig. 5. 
 
Fig. 8. Photoacoustic signals generated in a realistic tissue mimicking phantom before and after 
filtering at (a) λ = 460nm, (b) λ = 530nm, (c) λ = 590nm and (d) λ = 620nm. 
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5. Coded excitation 
The potential to arbitrarily modulate LEDs is a significant advantage compared to 
conventional Q-switched photoacoustic excitation laser sources, as it allows a variety of 
coded excitation schemes to be implemented. Such schemes provide the opportunity to 
increase the SNR of the photoacoustic signal as a function of N ,where N is the number of 
bits within the code. Coded excitation schemes can also be used to acquire photoacoustic 
signals at multiple wavelengths simultaneously by using a different orthogonal code for each 
wavelength, thus reducing acquisition time [14, 15]. 
To illustrate the implementation of coded excitation schemes using LEDs, photoacoustic 
signals were generated using Golay codes similar to those used to drive laser diode based 
photoacoustic excitation source [15, 16]. The scheme required that two biphase codes (e.g. A 
and B) of N bits, which can be positive or negative, are transmitted [16, 17]. To generate 
biphase codes, two unipolar codes representing the positive (e.g. Ap for code A and Bp for 
code B, see Fig. 9(a)) and negative (e.g. An for code A and Bn for code B) bits are transmitted. 
The generated photoacoustic signals (PAp and PAn for code A and PBp and PBn for code B) are 
then subtracted (e.g. PAp-PAn and PBp-PBn). The biphase codes are then cross-correlated with 
their respective photoacoustic signals and summed ((Ap-An)(PAp-PAn) + (Bp-Bn)(PBp-PBn)) 
in order to recover the desired signal. It is required that a total of four unipolar codes (Ap, An, 
Bp, Bn) are transmitted to obtain a complete data set (see Fig. 9). 
 
Fig. 9. Experimental setup and an example of a Golay excitation code (N = 8bit) based on 
transmission of four unipolar codes: Ap/An and Bp/Bn represent the positive (1) and negative 
(1) bits of the biphase code A and B respectively. T is the time delay between consecutive 
unipolar codes. 
The experimental setup shown in Fig. 9 was used to generate photoacoustic signals; the 
four colour LED described in the previous section was used. The setup comprised a cuvette 
filled with methylene blue (µa = 1.1 and 16mm
1
 at λ = 460 and 590nm, respectively) 
immersed in water to a depth of 5mm. The generated photoacoustic signals were detected 
using a planar PZT detector (3.5MHz, V381 Panametrics). Signals were amplified using a low 
noise voltage amplifier (Femto, 40dB) and downloaded to a PC. In this experiment, the LED 
elements were overdriven by only three times their rated current to reduce the likelihood of 
damage due to the increased duty cycle. Two different wavelengths (460nm and 590nm) of 
the four colour LED were driven with two different sets of orthogonal Golay codes 
simultaneously (shown in Fig. 9). Each Golay code was composed of four unipolar codes (An, 
Ap, Bn and Bp) of N = 8bits, and the time delay between consecutive unipolar codes was set to 
T = 5ms. The record length of the arbitrary wave function of the signal generator used was 
limited to 5000 points, for a time interval of 5ms this corresponds to a sampling interval of 
1μs and therefore each bit was 1µs long. 
The photoacoustic signals obtained using the Golay excitation method when emitting at 
both wavelengths simultaneously are shown in Fig. 10(a). The photoacoustic signals obtained 
using the conventional pulsed excitation method when emitting sequentially at each 
wavelength are shown in Fig. 10(b). The temporal shape of the photoacoustic signals obtained 
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with Golay excitation agree well with those obtained using the pulsed excitation. The SNR of 
the photoacoustic signals generated using Golay codes was 59 and 95 for 460nm and 590nm, 
respectively compared to 18 and 31 when using the pulse excitation method. This increase in 
SNR is consistent with an improvement of N , where N is the number of bits within the 
code (in this example N = 8). The total acquisition time, when using the Golay excitation 
method, was 20ms (4 unipolar codes each lasting 5ms), and 10ms (2 excitation pulses, one for 
each wavelength, with a time delay between pulses of 5ms) when using the conventional 
pulsed excitation method. However, to achieve the same SNR using the conventional pulsed 
excitation method, the detected photoacoustic signals would need to be signal averaged N 
times resulting in a total acquisition time of 80ms. 
 
Fig. 10. Photoacoustic signal generated via (a) Golay codes (b) pulsed excitation. A and B 
denote the photoacoustic signal and an acoustic reflection generated at the water air interface, 
respectively. 
6. Discussion and conclusion 
This study has explored the use of visible LEDs as photoacoustic excitation sources. By over-
driving with short high current pulses and operating at a low duty cycle, it has been 
demonstrated that pulse energies approaching 10µJ can be achieved using low cost (<$50) 
commercially available visible LEDs. By employing a high PRF in order to rapidly signal 
average, this enabled blood filled tubes immersed to a depth of 15mm in Intralipid to be 
detected. This suggests that in vivo imaging of the vasculature to depths of a few mm should 
be possible using a visible LED based photoacoustic excitation source. Note that large 
illumination beam diameters (>1cm) were used in the current study to illustrate the potential 
for use in widefield photoacoustic tomography. A previous study used a visible LED emitting 
at 623nm as an excitation source for single point measurements. However, its low pulse 
energy (400nJ) meant that focusing was required to generate a detectable photoacoustic signal 
thus limiting its practical application [6]. 
A novel highly compact four-wavelength LED was also evaluated to illustrate the 
potential for making multiwavelength photoacoustic measurements for spectroscopic 
applications. To mitigate the reduced pulse energy at each wavelength, two excitation 
strategies were investigated. The first used the signal generated using all four wavelengths 
simultaneously to design a Wiener filter which was then used to filter the signals generated at 
each individual wavelength to increase SNR. The second method used extended Golay coded 
excitation to increase SNR. In addition, by using different sets of orthogonal codes to drive 
elements emitting at different wavelengths, the simultaneous acquisition of photoacoustic 
signals at two wavelengths was demonstrated. This illustrates the potential of coded excitation 
schemes to provide faster acquisition than conventional sequential acquisition of 
photoacoustic signals at multiple wavelengths. 
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Even with future advances in signal processing and the realisation of Moore’s law type 
power scaling projections, it will be challenging for LED sources to cost-effectively match the 
output of conventional Q-switched Nd:YAG based excitation lasers. However this study 
suggests LEDs could find a role in superficial vascular imaging where the pulse energy 
requirements are relatively modest. In this context, a compact hand-held integrated LED 
based device employing widefield photoacoustic tomography for non-invasive dermatological 
investigations or oximetry type measurements can be envisaged. Applications may also lie in 
photoacoustic endoscopy or acoustic resolution microscopy [18] where the excitation beam is 
confined to some extent thereby further reducing the pulse energy requirements. LEDs may 
also be suitable excitation sources for OR-PAM; the pulse energies achieved in this study are 
certainly sufficient although the large emitting area of the LEDs used would make it 
challenging to achieve the necessary micron scale diffraction limited spot sizes. In all of these 
applications, visible LEDs could potentially be used in conjunction with near infrared laser 
diode sources to access a wide range of biologically relevant wavelengths in the 600-900nm 
spectral range for spectroscopic based discrimination or quantification (eg blood 
oxygenation). In summary it is considered that this work represents a step towards the 
development of compact, inexpensive visible and near infrared multiwavelength excitation 
sources for photoacoustic imaging. 
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